Filing Flows › Allogene Therapeutics (ALLO) › How it makes money
How Allogene Therapeutics (ALLO) makes money
Allogene Therapeutics (ALLO) made $4.6M of revenue in the second quarter 2026 (Q2 2026).
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $4.6M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $4.6M | — |
From Allogene Therapeutics' 10-Q filed Aug 12, 2026 (on EDGAR).
Questions
How does Allogene Therapeutics make money?
Allogene Therapeutics (ALLO) made $4.6M of revenue in the second quarter 2026 (Q2 2026).
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.